Design Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC DSGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

236,863

Value ($000)

2,222

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,222	0.0%	236,863	12/31/2025
2025 Q3	11/10/2025	1,867	0.0%	247,934	9/30/2025
2025 Q2	8/12/2025	846	0.0%	250,949	6/30/2025
2025 Q1	9/15/2025	997	0.0%	258,375	3/31/2025
2024 Q4	2/6/2025	1,633	0.0%	264,675	12/31/2024
2024 Q3	11/12/2024	1,385	0.0%	257,432	9/30/2024
2024 Q2	8/12/2024	603	0.0%	179,960	6/30/2024
2024 Q1	5/9/2024	722	0.0%	179,170	3/31/2024
2023 Q4	2/6/2024	465	0.0%	175,645	12/31/2023
2023 Q3	11/8/2023	410	0.0%	173,545	9/30/2023
2023 Q2	8/10/2023	1,441	0.0%	228,806	6/30/2023
2023 Q1	5/12/2023	1,329	0.0%	230,347	3/31/2023
2022 Q4	2/13/2023	2,369	0.0%	230,912	12/31/2022
2022 Q3	11/14/2022	3,755	0.0%	224,560	9/30/2022
2022 Q2	8/15/2022	1,887	0.0%	134,775	6/30/2022
2022 Q1	5/13/2022	1,977	0.0%	122,368	3/31/2022
2021 Q4	2/11/2022	2,539	0.0%	118,556	12/31/2021
2021 Q3	11/16/2021	1,330	0.0%	90,521	9/30/2021
2021 Q2	8/16/2021	1,746	0.0%	87,765	6/30/2021